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Abstract 
MAYA NADIMPALLI: Carriage of Antibiotic-Resistant Staphylococcus aureus by  
Livestock Workers and Household Members in North Carolina 
 (Under the direction of Dr. Jill Stewart) 
 
The growing animal reservoir of antibiotic-resistant Staphylococcus aureus is of public 
health concern. Industrial livestock operations are a potential source of exposure to these 
bacteria, which may be transmitted from animals to workers, and then to the community. To 
increase our understanding of occupational exposures to antibiotic-resistant S. aureus, we 
assessed nasal carriage of S. aureus, including multidrug-resistant S. aureus (MDRSA) and 
methicillin-resistant S. aureus (MRSA), among workers and household members from industrial 
livestock operations, antibiotic-free livestock farms, and meat processing plants in North 
Carolina.  We found a higher prevalence of MDRSA in industrial and processing plant 
participants compared with antibiotic-free participants, and comparable prevalence of MRSA. S. 
aureus belonging to clonal complex 398 was also discovered for the first time in North Carolina. 
This study contributes to the growing discourse regarding the public health consequences of 
large-scale antibiotic use in animal production in the United States. 
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CHAPTER 1: INTRODUCTION 
Staphylococcus aureus is a ubiquitous human commensal carried by approximately one 
third of the American population, primarily in the nostrils (Gorwitz et al., 2008). S. aureus is also 
an adept human pathogen capable of causing a wide range of infections, including skin and soft 
tissue infections, bacteremia, endocarditis, gastrointestinal illness, necrotizing pneumonia, post-
operative infections, and toxic shock syndrome (Loir et al., 2003; Lowy, 1998).  Antibiotics have 
been used to treat S. aureus infections for decades, but rapidly disseminating multidrug-
resistant strains of S. aureus (MDRSA) have made treatment more protracted, more 
burdensome, and less successful in recent years (Chambers et al., 2009). Methicillin-resistant S. 
aureus (MRSA) has proven particularly difficult to treat.  
Emerging in hospitals in the 1970s and rising dramatically in prevalence in the 1990s, 
MRSA is now established worldwide. These strains are resistant to β-lactam antibiotics, a 
commonly prescribed class of antibiotics that includes cephalosporins and carbapenems. 
Methicillin resistance is conferred by the mecA gene, which is typically acquired through 
horizontal gene transfer from another organism (García-Álvarez et al., 2011; Grundmann, 2006). 
The United States has higher rates of MRSA infection than most other industrialized countries, 
and American fatalities due to MRSA now surpass the combined annual mortality of HIV/AIDS, 
tuberculosis, and viral hepatitis (Bordon et al., 2010). Moreover, MRSA is no longer strictly a 
nosocomial infection. MRSA has evolved independently in the community, with cases occurring 
in healthy individuals having no connection to hospitals or other long-term care facilities. These 
highly virulent strains represent different genotypes from hospital-associated strains, and rates 
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of community-acquired MRSA infections are now rising faster than hospital-acquired MRSA 
infections in the United States. Community-acquired MRSA is currently considered epidemic in 
the United States (Kennedy et al., 2009).  
Most recently, the evolution of a community-acquired MRSA strain associated with 
intensive livestock production, primarily swine production, has been discovered. Although this 
novel strain of MRSA is believed to have originated from human-associated methicillin-
susceptible S. aureus (MSSA) strains (Price et al., 2012), it now persists in a livestock reservoir 
and can be transmitted between humans and animals. Multilocus sequence type 398 (ST398) 
was first detected in association with hog-farming in the Netherlands in 2004, and since then 
has been identified in several European countries as well as South America, China, Canada, and 
as of 2009, the United States (Arriola et al., 2011; Khanna et al., 2008; Smith et al., 2009; 
Wagenaar et al., 2009). Livestock-associated MRSA is transmitted not only to farm workers, with 
observed carriage rates between 23% and 49%, but their families as well (Huijsdens et al., 2006; 
R. Köck et al., 2009). MRSA and MSSA ST398 infections have also been documented in the 
greater community (Jiménez et al., 2011), including in individuals with no clear connection to 
livestock production (Bhat et al., 2009; Golding et al., 2010; Mediavilla et al., 2012; Skov, 2011; 
Uhlemann et al., 2012).   
Carriage of MDRSA and MRSA by North Carolina farm workers and their household 
members has not yet been investigated. North Carolina is the second largest producer of pork in 
the country and the third largest producer of poultry. The vast majority of these animals are 
housed from birth to slaughter in industry-owned concentrated animal feeding operations 
(CAFOs). North Carolina CAFOs confine thousands of animals in relatively small spaces, produce 
an estimated 20 million tons of concentrated animal waste annually, and typically dose livestock 
with low levels of antibiotics to promote growth and prevent disease (Cochran et al., 2000).  
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North Carolina, however, is also home to a burgeoning sustainable farming movement (Greene, 
2010).  These farms also raise pork and poultry, along with other animals and produce, without 
the use of antibiotics, and with limited reliance on external inputs. Given that the persistent, 
subtherapeutic dosing of animals with antibiotics could create a selective pressure for antibiotic-
resistant bacteria which could then be transmitted to humans (Khachatourians, 1998; Pew 
Charitable Trusts, 2008), a comparison of MDRSA and MRSA carriage rates among industrial 
workers and their household members to carriage rates among antibiotic-free farmers and their 
household members merits investigation.  
Objectives 
The goals of this research were four-fold: 
1) To compare the prevalence of carriage of MDRSA and MRSA in 100 consenting industrial 
livestock workers and household members to 100 antibiotic-free livestock workers and 
household members in North Carolina; 
2) To compare antibiotic resistance patterns among S. aureus-positive individuals in both 
groups;  
3) To use lineage-specific PCR to determine whether CC398 is present in North Carolina; and 
4) To compare the sensitivity and specificity of two differential media, Baird Parker and BBL™ 
CHROMagar™ Staph aureus, in their capacity to detect S. aureus from nasal swabs. 
The findings contained in this Master’s thesis will serve as a foundation for a more 
comprehensive evaluation of antibiotic resistance related to livestock production in North 
Carolina.  
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BACKGROUND 
Industrial Animal Production in the United States 
Within the past sixty years, animal production in the United States has shifted from 
many small, diversified family farms to fewer, larger, and highly specialized factory farms.  
Today, factory farming produces the vast majority of food animals raised and slaughtered in the 
US, and a small number of swine and poultry corporations oversee every aspect of the animal 
production process. This vertically integrated system can be characterized by standardization of 
feed, selective in-breeding of animals, and mechanization of feeding, watering, and other 
husbandry activities and aims to produce a more uniform meat product for the American 
consumer. The number of animals that are raised on each animal production operation has also 
surged – between 1994 and 2008, the number of animals per swine operation increased by 
180%, while the number of chickens per broiler operation increased by 130% (Pew Charitable 
Trusts, 2008).  By raising more animals within a concentrated, confined space, industrial 
operators are able to create “economies of scale,” shorten the time between birth and 
slaughter, and increase their profits. As a result of industrialization, the American consumer 
pays less for meat - in 1970, the average American spent 4.2% of his or her disposable income to 
purchase 194 pounds of red meat and poultry, while in 2005, Americans spent only 2.1% of their 
disposable income to purchase 221 pounds of red meat and poultry (Pew Charitable Trusts, 
2008). However, these prices do not reflect the human health and environmental costs of 
industrial animal production, which are instead externalized to society.  
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Industrial Animal Production: Public Health Concerns 
Environmental and health concerns 
Animal feeding operations in the United States produce an estimated 500 million tons of 
waste per year, three times more than the human population (United States Environmental 
Protection Agency, 2003). Roughly 47% to 60% of this waste is generated by CAFOs (Greger et 
al., 2010). Waste is collected and stored in large pits beneath caged animals or flushed into 
outdoor, open-air lagoons, which may serve as optimal breeding grounds for the bacteria that 
propagate antimicrobial resistance. In North Carolina, no further treatment is required of CAFO 
liquid manure before it is eventually sprayed onto fields. Over application of manure can lead to 
runoff laden with harmful pollutants, including nutrients, pesticides, heavy metals, veterinary 
pharmaceuticals, resistance genes, and infectious pathogens (Figure 1); these pollutants can 
also leach through permeable soil into aquifers. Lagoons themselves often leak, overflow, or 
rupture, which can also contaminate groundwater and surrounding surface waters (Sapkota et 
al., 2007; Steve  Wing et al., 2002). Exposure to waterborne contaminants can be particularly 
serious for vulnerable populations, including children, pregnant women, and the elderly 
(Reynolds et al., 2008).  
Air quality concerns are equally as pressing. Within confinement buildings, workers can 
be exposed to several categories of irritants, including bioaerosols, dust, toxic gases, and vapors 
from decomposing animal waste (Cole et al., 2000). The health effects of some of these toxic 
gases, including hydrogen sulfide, methane, ammonia, and carbon monoxide, are well-
documented (Cole, et al., 2000). However, thousands of gases and vapors are responsible for 
the malodor of CAFOs, most of which are difficult to quantify and whose health effects are 
unknown (Cole, et al., 2000). Bioaerosols, including bacteria, viruses, fungi, and endotoxins, and  
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dust from animal dander and waste pose 
further health risks. Acute occupational 
exposure to any combination of these 
irritants can result in shortness of breath, 
coughing, and inflammation of the lungs 
and mucous membranes; chronic exposures 
have been linked to bronchitis, asthma, and 
wheezing (Cole, et al., 2000). These health 
effects are also observed in the 
communities that surround CAFOs, due to 
both direct emissions and aerosolization of 
particulates during spraying. In combination 
with degraded mental and social health, 
lower quality of life measurements are 
often reported in such communities (S. 
Wing et al., 2000). 
Unfortunately, the environmental 
and health burdens of industrial animal 
production are not distributed equally 
among those who receive the “benefits” of 
this system. Instead, CAFOs tend to be 
disproportionately situated in areas of high 
poverty and a high percentage of non-
whites (S. Wing, et al., 2000). These 
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populations are often most susceptible to the environmental and public health harms produced 
by CAFO emissions and the land application of swine waste, due to lack of access to medical 
care, poor nutrition, and other risk factors. Furthermore, these groups often have the least 
political power to impact policies and practices related to industrial livestock operations in their 
communities. 
Propagation of antimicrobial resistance 
Twenty million pounds of antibiotics, or 80% of all antibiotics sold in the United States, 
are fed each year to industrially-raised animals (Food and Drug Administration, 2009). 
Antibiotics are used to treat sick or diseased animals, but are also chronically fed to healthy food 
animals for the purposes of prophylaxis and growth promotion. It is estimated that 
approximately 85% of the antibiotics given to food animals each year are for these latter two 
purposes (Pew Charitable Trusts, 2008). However, more than 50% of the types of antibiotics 
licensed for use in pigs are also used in human medicine (Mellon et al., 2001), and 
approximately 75% of the nearly 24.6 million pounds of antibiotics consumed for 
nontherapeutic purposes by livestock each year is excreted (Chee-Sanford et al., 2009). 
Industrial animal production has thus been linked to an increased animal and environmental 
reservoir of novel antimicrobial-resistant pathogens (Frank M. Aarestrup, 1995; Mathew et al., 
1999). Of serious public health concern is the close contact between workers and livestock in 
CAFOs, with the potential for transfer of antibiotic-resistant pathogens to workers, and 
subsequently the surrounding community. Handling or consumption of meat contaminated by 
antibiotic-resistant bacteria represents another potential exposure route, as multidrug-resistant 
pathogens, including S. aureus, have been repeatedly isolated from US retail meat and poultry 
(Gilchrist et al., 2007; O'Brien et al., 2012; Waters et al., 2011).  
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 In response to these concerns, leaders in Congress have called for an end to the use of 
clinically-relevant antibiotics in food animal production in the “Preservation of Antibiotics for 
Medical Treatment Act” (H.R. 965/S. 1211; PAMTA). In 2012, the FDA announced plans to place 
controls on the use of cephalosporins in animal production. More recently, the FDA was also 
court mandated to withdraw approvals for most non-therapeutic uses of penicillins and 
tetracyclines in food animals. However, PAMTA is still being debated, and any further regulation 
by the FDA may take years. Unfortunately, legislative and regulatory action could be outpaced 
by the evolution and dissemination of novel antimicrobial mechanisms. 
Food animal production in North Carolina 
Industrial animal production has grown rapidly in North Carolina in the past few 
decades, with the state moving from fifteenth to second in hog production nationally (Table 1), 
and from fourth to third in poultry production. North Carolina’s hog CAFOs are concentrated in 
the southern Piedmont and in the eastern coastal plain of the state, with the highest densities 
occurring in Duplin and Sampson counties. Together, hog production in these two counties 
accounts for nearly half of the state’s total production. Growth has leveled off in the last several 
years due to a moratorium on permitting new hog CAFO liquid waste storage lagoons (North 
Carolina Department of Agriculture and Consumer Services, 2010). Meanwhile, poultry 
production in North Carolina has increased in recent years. Turkey production is highest in 
Duplin and Sampson counties, but egg production occurs in the central part of the state and 
broiler production is increasing throughout the state. 
As it has across the United States, organic agriculture has expanded in North Carolina, 
particularly in the last decade (Table 2).  Organic farms are largely clustered in the central and 
western regions of the state. The total value of organic sales in 2008 was just above $50 million, 
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or 1.7% of total US sales (United States Department of Agriculture, 2010). North Carolina is the 
largest retailer of organic agricultural products in the Southeastern US.  
 
Table 1. Shift in NC hog production from 1982-2007 
Year Number of Operations Number of hogs 
1982 11,390 2.0 million 
2007 2,836 10.1 million 
Source: (Chee-Sanford, et al., 2009) 
 
Table 2. Growth in NC organic operations from 1997-2007  
Year # of operations # of cows, pigs, and sheep # of poultry 
1997 4 0 29,700 
2007 112 156 1,088,860 
Source: (Greene, 2010) 
Staphylococcus aureus 
Staphylococci are ubiquitous, gram-positive cocci which tend to cluster in grape-like 
bunches or in short chains. Most staphylococci are 0.5 to 1 µm in diameter, nonmotile, 
halotolerant to concentrations of 10% w/v NaCl, grow at temperatures between 18° and 40°C, 
and are aerobic or facultatively anaerobic (Murray et al., 2002).  Typically, staphylococci are 
found in association with the skin, skin glands, and mucous membranes of warm-blooded 
animals (Crossley et al., 1997). Staphylococci are one of the most common bacteria to cause 
disease in humans, and in the United States, staphylococci are the most common cause of 
nosocomial infection (Crossley, et al., 1997). Of at least 32 species, Staphylococcus aureus is the 
most pathogenic and consequently the best researched (Crossley, et al., 1997).   
 The structure of S. aureus and its production of virulence factors and exotoxins are 
critically related to its fitness as a human pathogen.   Like all staphylococci, S. aureus has a thick 
cell wall composed of peptidoglycan, and several serotypes also have a protective 
polysaccharide capsule that facilitates adherence to surfaces and evasion of the immune system 
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(Murray, et al., 2002). S. aureus can be distinguished from other species of staphylococci by its 
ability to produce coagulase, a protein which binds fibrinogen in the blood and converts it to 
insoluble fibrin, thus localizing an infection and protecting the bacteria from immune response 
cells.  S. aureus also uniquely produces surface protein A, a cell-wall bound protein which is 
involved in increased pathogencity of the organism.  S. aureus’ fitness is further enhanced by its 
production of staphyloxanthin, a carotenoid pigment that acts as a protective antioxidant while 
imparting a characteristic golden color to S. aureus colonies. Several strains of S. aureus are 
capable of producing a variety of exotoxins, including TSST-1 (associated with toxic shock 
syndrome), exfoliative toxins (associated with staphylococcal scaled skin syndrome), 
staphylococcal enterotoxin B (associated with food poisoning), and α toxin, β toxin, and Panton-
Valentine leukocidin (all associated with necrotizing pneumonia) (Lowy, 1998). The production 
of these proteins and toxins allows S. aureus to cause a wide diversity of benign and lethal 
infections.  
Though humans and animals are its primary reservoir, S. aureus has also been detected 
in air (Bassetti et al., 2005), in drinking and waste waters (LeChevallier et al., 1980; Rosenberg-
Goldstein, 2010), and in food (Loir, et al., 2003). It has been demonstrated that S. aureus can 
persist in river and sea water for up to two weeks (Tolba et al., 2008), as well as on dry surfaces 
for days to months (Kramer et al., 2006). S. aureus has also been detected in hog and poultry 
waste (Dimitracopoulos et al., 1977; Graham et al., 2009). 
Epidemiology of S. aureus carriage 
Though S. aureus can be highly pathogenic, only a fraction of the S. aureus that exists in 
the human population actually causes disease.  According to data from the 2001-2004 National 
Health and Nutrition Examination Survey (NHANES), approximately 1/3 of American men and 
women harbor S. aureus in their nasal passages (Gorwitz, et al., 2008), which is the preferential 
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site for S. aureus colonization. An additional 20% of the population carry it on their skin, hair, or 
in their throats (Bhatia et al., 2007). Nasal carriage of S. aureus is not evenly distributed among 
the US population. Rather, colonization with S. aureus has been found to be significantly more 
common among males, compared with females (p<.001), among non-Hispanic whites and 
Mexican Americans, compared with non-Hispanic blacks (p<.001 and p<.01, respectively), and 
among persons aged <20 years, compared with older persons (p<.001) (Gorwitz, et al., 2008). 
Rates of staphylococcal colonization are higher than average among intravenous drug users, 
individuals with type 1 diabetes, and AIDS patients (Lowy, 1998). Significant associations 
between obesity and S. aureus carriage have also been described (Gorwitz, et al., 2008). 
Importantly, carriage of S. aureus can be transient. Longitudinal studies have described three 
patterns of S. aureus carriage in the population: persistent carriers, who are thought to 
comprise 20% of the population, persistent non-carriers, who are thought to comprise an 
additional 20% of the population, and intermittent carriers, who are thought to comprise the 
remaining 60% of the population (Peacock et al., 2001).  Though concrete population 
determinants of carriage remain speculative, race, genetics, immune characteristics, strain 
diversity, and environment may play a role. While nasal carriage may be a risk factor for 
infection, most individuals who are colonized never become infected (Gorwitz, et al., 2008). 
Eradication of nasal colonization via mupirocin treatment may or may not prevent subsequent S. 
aureus infection (Wertheim et al., 2005). 
 Carriage of methicillin-resistant strains of S. aureus is far less common than carriage of 
S. aureus in general. As of 2005, MRSA was estimated to be carried by 1.5% of the US 
population, though rates were steadily increasing (Gorwitz, et al., 2008). Risk factors for MRSA 
acquisition include hospitalization, use of antibiotics, previous colonization with MRSA, drug 
use, old age, low socioeconomic status (Charlebois et al., 2002; Gorwitz, et al., 2008),  
12 
 
imprisonment (Aiello et al., 2006),  use of  work-out gyms (Kirkland et al., 2008), and pig farming 
(Voss et al., 2005). While hospital-acquired MRSA strains were once predominant in the US, they 
are largely being replaced by community-acquired strains. Longitudinal studies have 
demonstrated that increasing rates of MRSA infection in the US in the early 2000s were linked to 
an expanding reservoir of such community-associated strains (Carleton et al., 2004). 
History of antibiotic resistance in S. aureus 
In the 1940s, penicillin became the first commercially available antibiotic, and its 
discovery heralded a new age of pathogen control. Almost simultaneously, however, there came 
reports of certain staphylococci that could destroy the antibiotic through production of an 
enzyme then termed “penicillinase.” Penicillin acts by binding to and inhibiting penicillin binding 
proteins (PBP), which are integral in catalyzing the peptidoglycan cross-links in bacterial cell 
walls. As bacteria continue to naturally degrade peptidoglycan links without the capacity to 
construct new ones, their cell structure weakens, resulting in lysis. Penicillinase, encoded by the 
blaZ gene, hydrolyzes the β-lactam ring of penicillin before it can act, thus protecting bacteria 
from the antibiotic’s mode of action (Lowy, 1998). As early as 1946, it was estimated that 60% of 
hospital S. aureus isolates in the UK were resistant to penicillin; current estimates top 90% 
(Crossley, et al., 1997). Penicillin-resistance is now nearly ubiquitous in S. aureus (Crossley, et al., 
1997). 
 Methicillin was introduced into clinical practice in the early 1960s to combat the surge 
of penicillin-resistant S. aureus. However, only a few years later, the first methicillin-resistant 
strains of S. aureus were isolated. Though the mechanism for the observed resistance was not 
discovered until 20 years later, it was immediately clear that this mechanism was wholly 
independent from penicillinase production (Chambers, et al., 2009). While penicillinase 
production confers only a narrow range of resistance, methicillin-resistance confers resistance 
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to all β-lactam antibiotics, including carbanepems and cephalosporins. The gene responsible for 
this resistance, mecA, encodes for an altered penicillin-binding protein (PBPa), which has a 
lower affinity for all β-lactam antibiotics. When bacteria produce PBPa, cell wall synthesis is able 
to proceed unaffected in the presence of β-lactams. At least 4 distinct waves of mecA-encoded 
methicillin-resistance have been observed, resulting in the global MRSA pandemic occurring 
today. 
Vancomycin-intermediate and vancomycin-resistant S. aureus (VISA and VRSA) have 
emerged in the last decade as a result of the rising use of vancomycin to treat MRSA infections. 
However, VISA and VRSA infections remain few in number and have been isolated exclusively in 
the healthcare setting (Chambers, et al., 2009). VRSA carry the vanA gene cassette, presumably 
obtained from vancomycin-resistant Enterococcus (Chang et al., 2003). Carriage of this cassette 
appears to present a significant burden on the bacteria, which may account for the limited 
spread of VRSA in hospitals and its absence from the community (Foucault et al., 2009). The 
mechanisms for low-level and intermediate vancomycin resistance remain unclear, though 
certain morphological changes in VISA, such as cell wall thickening and intensive pigmentation, 
have been observed (Renzoni et al., 2010).  
 Presently, S. aureus has developed a resistance mechanism for every class of antibiotics 
ever produced by humans, including many last-line-of-defense antibiotics (Skov, 2011). As is 
clear from its long history of antibiotic resistance, these organisms have the alarming propensity 
to rapidly disseminate resistance mechanisms when selective pressures exist. Reducing drug 
resistance in S. aureus will likely require a more judicious use of antibiotics in humans and 
animals, prevention strategies rather than control, and perhaps the development of alternative 
treatments, such as vaccines (Daum et al., 2011).  
14 
 
Mechanisms for antibiotic resistance 
One of the most important mobile genetic elements (MGEs) encoding resistance in S. 
aureus is the Staphylococcal Cassette Chromosome mec (SCCmec; see Figure 2). SCC elements 
are genomic islands that are ubiquitous among staphylococci; SCCmec contains the mecA gene 
and is most commonly associated with MRSA (although partial, nonfunctional SCCmec 
sequences – known as “ghost sequences” - have been detected in MSSA) (Corkill et al., 2004). 
SCCmec elements are 20 - 66 kb in length and are integrated at the 3’ end of the orfX gene, 
whose function remains unknown. These elements carry two major complexes: the mec 
complex, encoding the mecA gene and two regulatory genes (mecI and mecRI), and the ccr 
complex, which encodes for one or two site-specific cassette chromosome recombinases, 
allowing the SCCmec element to be excised and inserted into new genomes (Deurenberg et al., 
2007). Between these complexes and the 3’ and 5’ ends of the SCCmec lie three junkyard, or 
joining regions: J3, located between orfX and mec, J2, located between mec and ccr, and J1, 
located between ccr and the chromosomal region flanking the SCCmec.  Several allotypes of the 
mec and ccr complexes have been identified, and SCCmec elements can be typed based on 
these differences. SCCmec types I-VIII are the most well-known, though several other types 
likely exist. Subtyping of SCCmec is also possible by classifying structural differences in the J1, J2, 
and J3 regions. In addition to the mecA gene, certain SCCmec complexes (namely II and III) 
encode additional drug resistance genes on integrated mobile elements, such as plasmids and 
transposons (Skov, 2011). 
 
 
Figure 2. Skeletal representation of the SCCmec element. 
orfX 
3’ 5’ 
J3 J2 J1 
mec complex ccr complex 
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S. aureus can carry resistance genes inserted at other sites on the chromosome besides 
SCCmec, as well as on plasmids (Deurenberg, et al., 2007). Additionally, S. aureus can develop 
resistance through random mutation of existing genes. Such mutations require selective 
pressure to maintain themselves in subsequent generations. 
Molecular typing of S. aureus 
Molecular typing originally evolved as an epidemiological tool to track the dissemination 
of MRSA strains into regional and global populations. However, any strain of S. aureus can be 
typed by any of these same methods. The typing methods that will be discussed here are: 
pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), typing of the 
variable tandem repeat region of surface protein A (spa typing), and whole genome sequence 
typing (WGST).  
Pulsed-Field Gel Electrophoresis 
PFGE is typically considered the gold standard for typing S. aureus isolates, as it is one of 
the most discriminative methods for studying outbreaks and transmission patterns (Deurenberg, 
et al., 2007). PFGE typing of S. aureus involves the digestion of chromosomal DNA with the 
restriction enzyme Sma1, followed by agarose gel electrophoresis.  Sma1 cuts genomic DNA at 
specific, infrequent restriction sites, resulting in ten to twenty very large DNA fragments. These 
fragments are too large to be separated by traditional gel electrophoresis; however, by 
constantly changing the direction of the electric field during electrophoresis, PFGE is able to 
facilitate an efficient separation. PFGE patterns are analyzed using the Dice coefficient and 
unweighted pair-group matching analysis (UPGMA) settings, allowing for identification of a 
species and subtype (Deurenberg, et al., 2007). Unfortunately, because small changes in lab 
protocol can result in different PFGE patterns, inter-lab reproducibility and pattern comparison 
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are difficult if standardized protocols are not used.   Thus, standardized PFGE databases have 
only been achieved at the national level (Deurenberg, et al., 2007). Additional drawbacks of 
PFGE typing include high cost and time requirements, and the need for trained lab personnel.  
ST398 - the strain associated with intensive livestock production, is also “nontypeable” by PFGE 
using Sma1 (Voss, et al., 2005).  
Multilocus Sequence Typing 
MLST is a relatively new typing method that also demonstrates excellent discriminatory 
power (Maiden et al., 1998). MLST involves sequence analysis of 0.5-kb internal fragments of 
seven S. aureus housekeeping genes: arcC, aroE, glpF, gmk, pta, tpi, and yquiL. Differences in 
these sequences correspond to distinct alleles for each housekeeping gene. Each allele is 
assigned a unique number; any S. aureus isolate can be identified by its allele profile for these 
seven genes, also known as its “sequence type.” A major advantage of MLST over PFGE is that 
sequence data are truly commutable across laboratories and across countries. Currently, there 
exists one global database containing all known sequence types (http://mlst.net), to which any 
researcher can upload new alleles. Global epidemiological investigations of MRSA and MSSA 
infection are thus possible using MLST. Unfortunately, like PFGE, MLST is also time-consuming 
and expensive. 
 MLST does allow some insight into the clonal evolution of S. aureus. S. aureus strains are 
grouped into the same “clonal complex” (CC) when 5 out of their 7 housekeeping genes have 
identical sequences. The founder of a CC is calculated as the ST that differs from the largest 
number of other STs at only a single locus, rather than the ST that is detected most frequently 
(as this is subject to sampling bias). This methodology for determining a CC founder takes into 
account the way clones actually emerge and diversify. Subgroup founders are single-locus or 
double-locus variants of a CC founder.  These variants may become prevalent in the population, 
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and may diversify independently to produce their own set of single-locus and double-locus 
variants (Deurenberg, et al., 2007). A constantly updated diagram depicting all known clonal 
complexes and their relationships to one another is available at http://eburst.mlst.net.  
Spa typing 
Spa typing is even more discriminatory than MLST, and is much less costly since it 
involves sequencing of only a single locus. The gene encoding surface protein A is unique to S. 
aureus and contains a polymorphic region X, which is characterized by one to twenty-five 24-bp 
tandem repeats. Diversity in repeats is attributed to duplications of repeats, deletions, and less 
commonly, mutations (Deurenberg, et al., 2007). However, the first repeat in region X always 
begins with the sequence GAG, while subsequent repeats always begin with AAA (M. Sørum, 
personal communication, November 26, 2011). Sequencing the spa gene reveals how many 
tandem repeats are present in a strain, which repeats they are, and in what order they occur; 
this corresponds to a certain spa type.  Researchers can identify spa types as well as upload 
novel spa types using a central spa server, available at http://www.spaserver.ridom.de.  Because 
of its simplicity, low cost, and the fact that it can be performed using “in-house” technologies, 
this typing method is used widely in hospitals and research labs (Deurenberg, et al., 2007; 
Sørum, 2011).  
Usually, once the spa type of a specific S. aureus strain has been determined, it is 
possible to infer its sequence type and therefore the clonal complex to which it belongs (Nulens 
et al., 2008). However, it is important to note that spa typing and MLST result in two different 
sets of data that are not always comparable. Inferences are usually permissible because there 
are several known spa types that correspond to a single ST type. However, chromosomal 
recombination has occurred among different S. aureus lineages, complicating such assumptions 
(Nulens, et al., 2008). For example, CC8, has acquired part of its core genome from CC30, 
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including its spa gene. As a result, spa-CC012 has a heterogeneous clonal structure that includes 
both CC8 and CC30, and its ancestry cannot be inferred. To be absolutely sure of a strain’s 
sequence type and clonal complex, MLST must be performed in addition to spa typing (M. 
Sørum, personal communication, November 26, 2011). 
Additionally, there exist two competing nomenclature systems for spa types which are 
used worldwide (Harmsen et al., 2003; Koreen et al., 2004). This renders comparison of 
published spa typing results considerably more difficult than comparison of MLST typing results.  
Whole genome sequence typing 
Whole genome sequence typing (WGST) represents the newest, best available method 
for tracking S. aureus subtypes at both the global and regional scale. Though PFGE is considered 
the gold standard for typing S. aureus isolates and for epidemiological investigations, it is only 
able to discriminate interregional isolates – i.e., it lacks the power needed to discriminate subtle 
intraregional variability (Harris et al., 2010). Such discriminatory power is needed to understand 
the microevolutionary events that lead to clonal differentiation. Unlike full-genome sequencing, 
which is economically unfeasible and too time-consuming for large population samples, WGST 
instead maps single nucleotide-polymorphisms (SNPs) in given strains to a reference genome. 
Next-generation sequencing technologies allow multiple bacterial isolates at be mapped at 
once, thus making it feasible to quickly generate whole-genome sequence data for a large 
number of bacteria (Harris, et al., 2010). From this sequence data, the SCCmec type, sequence 
type, and spa type for any given bacterial isolate can be determined. Additionally, resistance 
genes, virulence genes, and other MGEs that may be incorporated in the accessory genome are 
revealed.   
 Data produced by WGST is especially useful for generating maximum likelihood 
phylogenetic trees, which are constructed by comparing the variable sites in the core genomes 
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of sequenced bacteria.  S. aureus isolates from specific geographical regions tend to cluster on 
such trees; clades that are basally located elucidate where an S. aureus strain may have 
originated (Harris, et al., 2010). Phylogenetic trees can also explain whether or not a certain 
strain was introduced to a country or if it evolved independently. If it was introduced, its origin 
can typically be determined. Phylogenetic trees constructed from WGST data were used to 
determine the source of the recent cholera outbreak in Haiti (Hendriksen et al., 2011), as well as 
to corroborate the assumed source of MRSA ST398 in two adopted Chinese children in Denmark 
(Stegger et al., 2010). WGST data potentially has sufficient discriminatory power to reveal fine-
scale transmission events between or within single hospitals (Harris, et al., 2010).  PFGE and spa 
typing findings do not always correspond with evolutionary relationships delineated by WGST 
(Harris, et al., 2010), suggesting WGST may be a superior tool for epidemiological investigations.  
 WGST is currently a more expensive S. aureus typing method, although prices for next-
generation sequencing technology are declining rapidly. Bioinformatics expertise is also required 
to interpret WGST data and to construct phylogenetic trees. Therefore, WGST may not yet be 
suitable for routine use outside of highly specialized research laboratories. 
Methicillin-resistant Staphylococcus aureus 
The first case of MRSA was described in the UK in 1961 (Deurenberg, et al., 2007), and 
the first documented hospital outbreak followed soon after in 1963 (Stewart et al., 1963). MRSA 
is now endemic globally and is epidemic in many US hospitals, long-term care facilities, and 
communities (Klein et al., 2007). The US has higher rates of MRSA infection than most other 
industrialized countries (Bordon, et al., 2010). As of 2005, there were approximately 278,000 
hospitalizations related to MRSA in the US (Klein, et al., 2007). Among these hospitalizations, 
94,000 were for first-time invasive MRSA infections, 1 in 5 of which resulted in death (Klevens et 
al., 2006). The most recent national survey of MRSA in US hospitals suggests that prevalence 
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may be decreasing; from 2005-2008, there was approximately a 28% decrease in hospital-onset 
MRSA infections and a 17% decrease in community-onset infections (Kallen et al., 2010). It is 
estimated that MRSA infections cost the healthcare system up to an additional $9.7 billion 
annually (Klein, et al., 2007). Many MRSA infections tend to be multiply drug-resistant (Bordon, 
et al., 2010), further compounding the costs of treatment.  
 As described previously, methicillin resistance is conferred by acquisition of the mecA 
gene, which is carried on the SCCmec element. The source of SCCmec is unknown, although 
coagulase-negative staphylococci (CoNS) are thought to have first transferred this MGE to S. 
aureus (Skov, 2011).  Evidence suggests that MRSA clones do not have a single ancestor; instead, 
SCCmec was introduced multiple times into different S. aureus lineages, resulting in the clonal 
diversity observed today (Deurenberg, et al., 2007). It should be noted that carriage of the 
SCCmec element is not inherently beneficial to S. aureus, as it is associated with a weaker cell 
wall (Skov, 2011).  Therefore, antibiotic pressure is required to facilitate dissemination of 
SCCmec into MSSA. 
 In 2011, a novel mecA gene, homologue mecALGA251 and herein termed “LGA251”, was 
discovered by researchers at the University of Cambridge.  LGA251 shares 70% similarity to the 
conventional mecA gene at the DNA sequence level, and 63% similarity at the amino acid level 
(Fluit, 2011). LGA251 is carried by SCCmec-IX, a novel SCCmec element (García-Álvarez, et al., 
2011).  S. aureus isolates carrying this gene were first isolated from bulk milk and English dairy 
cattle, and then confirmed in archived human isolates from England, Scotland, and Denmark 
(García-Álvarez, et al., 2011).  It is not known when this homologue emerged, although its 
presence has been confirmed in a Danish human isolate dating as far back as 1975 (Holmes, 
2011). It is also unknown whether or not this mec gene confers an advantage over the 
conventional mecA gene, although an increasing occurrence in Danish human isolates from 
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2008-2010 was statistically significant (Holmes, 2011). The LGA251 gene homologue has only 
been detected in “animal-associated strains” thus far, and has not been detected in any S. 
aureus isolate from the United States (Holmes, 2011). Efforts are now underway to allow for the 
simultaneous detection of mecA and its homologue using clinical diagnostic tools (M. Stegger et 
al., 2011).  The discovery of LGA251 highlights the importance of scrutinizing S. aureus isolates 
that demonstrate methicillin-resistance but are PCR-negative for the mecA gene.  Other 
homologues of the mecA gene, besides LGA251, may in fact exist.  
History of MRSA 
Wave 1: 1960s – mid 1970s 
The first wave of MRSA to hit Europe was essentially monoclonal, with all archived 
isolates belonging to a single subgroup of CC8 (Enright et al., 2002). Isolates from this subgroup 
carried the first characterized SCCmec (SCCmec I), and most were ST250. This sequence type is 
now archaic; a defective ccr complex prevented SCCmec I from transferring effectively to MSSA, 
causing the first MRSA strains to die out completely by the 1980s (Skov, 2011). While ST250 
isolates no longer cause epidemic MRSA disease, a minor variant (ST247–MRSA-I; also known as 
the “Iberian clone”) is one of the major MRSA clones detected in European hospitals and has 
evolved resistance to most antimicrobial agents (Enright, et al., 2002). MRSA infections from this 
first wave were largely contained to Europe, with isolated reports of MRSA infection in the US 
(Chambers, et al., 2009; Skov, 2011). 
Wave 2: Late 1970s – present 
In the late 1970s, the mecA gene was incorporated into two new chromosomal 
cassettes, SCCmec types II and III, both of which were successfully introduced into MSSA strains. 
Outbreaks were reported globally, and infections became endemic by the 1980s. This MRSA 
wave was initially dominated by CC5 and CC8, though SCCmec types II and III emerged in CC30 in 
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the 1990s (Skov, 2011). Both of these elements are very large (52 and 66 kb, respectively) due to 
the accumulation of multiple genes encoding resistance to antibiotics and heavy metals. While 
selective pressure for these elements exists within hospitals, their large size likely precluded 
them from ever gaining success in community-associated (CA) MSSA strains (Ma et al., 2002).  
Both of these SCCmec types continue to circulate globally, primarily in hospitals. 
Wave 3: Late 1980s – present 
The third wave of methicillin-resistance in S. aureus was marked by the emergence of 
the new, relatively small SCCmec type IV (20-24 kb). This MGE is uniquely devoid of genes 
encoding resistance to antibiotics or metals. However, its small size allows strains carrying this 
element to efficiently compete with natural human flora. SCCmec IV first emerged in novel 
hospital-associated (HA) clones CC22 and CC45, and then began replacing SCCmec II and III in 
CC5 and CC8 (Skov, 2011).  By the 1990s, approximately 90% of the HA-MRSA circulating 
worldwide belonged to only five clonal complexes: CC5, CC8, CC22, CC 30, and CC45 (Skov, 
2011). Many of these clonal complexes are still associated with HA infections.  
Next, SCC mec IV began to transfer to MSSA lineages completely separate from typical 
HA strains. These new MRSA strains were able to multiply and spread outside of the hospital 
environment.  Reports of CA-MRSA infections date back to the 1980s, but these strains were 
only able to truly establish themselves in the 1990s. Today, CA-MRSA infections are considered 
epidemic in many parts of the world, including the US (Kennedy, et al., 2009). 
Community-associated MRSA differs from hospital- associated MRSA in many respects. 
CA-MRSA carries much smaller SCCmec elements; in addition to SCCmec type IV, many other CA-
MRSA-associated SCCmec types have emerged, including types V, VII, VIII, and XIII. CA-MRSA 
typically carries the Panton-Valentine leukocidin (pvl) gene, a human-specific virulence factor. 
CA-MRSA infections present mainly as skin and soft tissue infections, and risk factors include 
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close contact with an individual colonized with CA-MRSA, contact sports, crowding or living in 
close quarters, intravenous drug use, and homosexual activity (Skov, 2011). CA-MRSA also tends 
to be less drug resistant than HA-MRSA, though this is highly strain-dependent. Importantly, CA-
MRSA infections can easily occur in healthy individuals. Due to its increased fitness and 
virulence, CA-MRSA has begun to replace HA-MRSA in the hospital and long-term care facility 
settings, therefore blurring the traditional distinctions between “HA-MRSA” and “CA-MRSA.” 
Nosocomial outbreaks of CA-MRSA have been reported since 2003 (Otter et al., 2006). 
Wave 4: 2004 – present 
In 2004, a new strain of MRSA was unexpectedly found in a 6-month old Dutch girl and 
her parents. The strain was untypeable by PFGE using Sma1 and resisted decolonization (Voss, 
et al., 2005). Neither the girl nor her parents had any traditional risk factors for MRSA 
colonization; however, they were pig farmers and lived on a farm. Further investigation revealed 
that some of the family’s pigs were carrying the same strain as the girl and her parents, as were 
several individuals who had recently visited their farm (Voss, et al., 2005). The new strain was 
designated as ST398, belonging to the new clonal complex 398. By 2005, MRSA ST398 was 
confirmed in humans and pigs across the Netherlands (Huijsdens, et al., 2006). Livestock-
associated (LA) MRSA has since been detected in in pigs and pig farmers in multiple European 
countries, including France, Denmark, Belgium, and Spain, as well as in South America, China 
(where LA-MRSA occurs in ST9), Canada, and as of 2009, the United States (Smith et al., 2011). 
LA-MRSA represents the fourth and most recent wave of methicillin-resistance in S. aureus.  
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Livestock-associated ST398 
Origins of MRSA ST398 
Though MRSA has been described in livestock since 1972, ST398 represents the first 
known transmission of MRSA from livestock to humans (Price, et al., 2012). Evidence suggests 
that MRSA ST398 emerged due to the repeated introduction of SCCmec IV and V into precursor 
MSSA ST398 strains that existed in pigs and in their environment. These precursor strains are 
thought to be human in origin and were transmitted to pigs an indeterminable length of time 
ago (Price, et al., 2012). It is not clear whether or not the emergence of MRSA ST398 at varied 
geographic locations can be attributed to de novo emergence on multiple farms from multiple 
MSSA ST398 reservoirs, or whether transmission among farms and animals is the more probable 
cause (Smith, et al., 2011). 
Characteristics of MRSA and MSSA ST398 
Livestock-associated ST398 is highly unique from S. aureus strains observed previously. 
First, almost all livestock-associated ST398 isolates are tetracycline-resistant, and a majority of 
MRSA ST398, although rarely MSSA ST398, exhibit zinc resistance encoded by the crcZ gene 
(Lina M. Cavaco et al., 2011). A vastly diverse antibiotic resistance pattern is observed among 
ST398 isolates, indicating that selective pressure for this strain is variable yet sustained (Skov, 
2011).  Second, the core genome of this strain is markedly different from “human” MSSA strains 
(Skov, 2011). This corroborates the theory that LA-ST398 evolved in a non-human reservoir. 
Third, most ST398 isolates carry the SCCmec V element, though several novel SCCmec types 
have been discovered in these isolates. Fourth, MSSA and MRSA ST398 isolates typically lack the 
pvl gene, though some exceptions exist (Wulf, & Voss, 2008). Lastly, LA-MRSA has so far proven 
to be significantly less transmissible among humans than other MRSA strains. Current reports 
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rate nosocomial transmission of MRSA ST398 as 72% less likely than transmission of non-ST398 
MRSA strains (Wassenberg et al., 2011). However, the possibility that transmission of ST398 will 
increase as the strain becomes better adapted to humans is of great concern. This is particularly 
alarming since the swine reservoir of ST398 is enormous, and likely cannot be eliminated. 
Importantly, pigs may not be the only livestock reservoir of ST398; carriage has also been 
detected in poultry, cattle, and horses (Nemati et al., 2008; Van den Eede et al., 2009; 
Vanderhaeghen et al., 2010).  
ST398 Infection 
MRSA and MSSA ST398 have been responsible for a wide diversity of minor and 
localized infections, including abscesses, urinary tract infections, wound infections, mastitis, and 
conjunctivitis (Smith, et al., 2011). Much more serious infections include bacteremia, 
pneumonia, osteomyelitis, otomastoiditis, and post-operative infections (Smith, et al., 2011). 
Currently, most ST398 infections present as skin and soft tissue infections (Smith, et al., 2011). 
The vast majority of ST398 infections have occurred in the last five years, although a disease-
causing MSSA ST398 isolate was archived in Denmark in 1992 (Smith, et al., 2011).  
A rising number of ST398 infections have recently begun to occur in individuals with no 
documented livestock contact. Isolates causing such infections are often referred to as “human-
associated ST398,” rather than “livestock-associated ST398.” Human-associated MSSA ST398 
infections have been documented in China, New York, and New Jersey, and 10% of MRSA ST398 
cases in Denmark are now human-associated (Mediavilla, et al., 2012; Skov, 2011; Smith, et al., 
2011; Uhlemann, et al., 2012). It is unclear whether these strains are related to the human-
associated MSSA precursors that gave rise to LA-MRSA ST398, or whether they have evolved 
from LA-MRSA ST398. Regardless, analysis suggests that the occurrence of several MGEs, 
surface adhesins, and the ability to bind to human keratinocytes may make human-associated 
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ST398 better suited for human infection than traditional livestock-associated isolates 
(Uhlemann, et al., 2012). 
Colonization versus Contamination 
It has not clear whether occupational exposure to colonized pigs results in persistent 
ST398 carriage, or if individuals only become transiently contaminated. Several studies from the 
Netherlands suggest the latter, while a more recent study from Germany suggests the former. A 
2009 study was the first to find that veterinarians who worked with pigs often tested positive 
for MRSA carriage, but only on the day of their visit (Van Den Broek et al., 2009). A longitudinal 
study conducted by Graveland et al. later found that MRSA carriage in veal calf farmers was 
strongly related to duration of animal contact, with odds of carriage significantly reduced during 
periods of low exposure (Graveland et al., 2011).  A third study found veal farmers were 94% 
less likely to carry MRSA 24 hours after animal exposure, compared to immediately after 
exposure (van Cleef et al., 2011). However, a 2012 study found that 59% of German pig farmers 
did not clear MRSA colonization following summer holidays, suggesting that regular contact with 
swine may lead to persistent carriage (Robin Köck et al., 2012). Overall, these studies present 
conflicting evidence regarding whether or not MRSA ST398 “carriage” is an artifact of short-term 
exposure to MRSA-contaminated bioaerosols, or whether carriage truly represents persistent 
colonization.   
ST398 in North America 
ST398 and hog farms 
ST398 was first reported in North American hogs and workers in 2008. Twenty-five 
percent of pigs and 20% of workers from 20 farms in southwestern Ontario, Canada were found 
to carry MRSA, with almost 60% of isolates belonging to spa types associated with ST398 
(Khanna, et al., 2008). In total, 45% of the sampled farms were contaminated with MRSA, 
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though not all with ST398.  Though a few ST398 infections have been reported, infection by 
ST398 remains rare in the greater Canadian population (estimated at 0.14%) (Golding, et al., 
2010).  
 The only published report of MRSA ST398 on a US pig farm was from Iowa in 2009. 
Smith et al. investigated two conventional CAFO systems in Iowa, each comprising over 25,000 
animals in total. In the first production system, 209 pigs were swabbed, 70% of which were 
colonized with ST398. Nine out of 14 workers also carried this same strain. Curiously, in the 
second production system, no pigs (90 sampled) and no workers (6 sampled) carried ST398 
(Smith, et al., 2009). Hypotheses provided for this discrepancy included the confirmed 
importation of pigs from Canada by the first production system, the presence of nearly twice the 
number of hogs in the first production system compared to the second, and the older, more 
established nature of the first production system (Smith, et al., 2009). However, the authors did 
not research this discrepancy further. Prevalence of MRSA ST398 has not been further 
investigated in pigs or workers in CAFOs elsewhere in the United States. 
ST398 and retail meat 
Two recent studies have documented the presence of ST398 on retail meat in the 
United States. A 2011 study examined the presence of multidrug-resistant S. aureus, or S. aureus 
demonstrating intermediate or complete resistance to three or more classes of drugs, on 
conventionally-raised meat in the US. Researchers discovered MSSA ST398 on turkey, chicken, 
and pork samples (Waters, et al., 2011). ST398 was the predominant strain recovered from 
turkey (79%), the second most common strain found on pork (18%), and one of the least 
common strains found on chicken (4%). ST398 was not recovered from beef (Waters, et al., 
2011). Most ST398 isolates recovered from retail meat were multidrug-resistant. A 2012 study 
isolated MRSA from 6.4% of conventional pork samples and 7.4% of alternative pork samples 
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(raised without the use of antibiotics) (O'Brien, et al., 2012). Over a quarter of the pork samples 
that tested positive for MRSA had spa types associated with ST398. The authors speculated that 
the presence of MRSA on alternative pork products might be a result of contamination during 
processing, as the study’s results were incongruous with previous findings in Europe (O'Brien, et 
al., 2012). Although S. aureus is destroyed by cooking, contact with contaminated meat could 
result in nasal colonization, cross-contamination of surfaces, and/or introduction of ST398 into 
the home environment. 
Prevalence of ST398 in the US population 
Carriage of MRSA ST398 in the general US population is unknown due to poor national 
surveillance, particularly in rural areas. However, no symptomatic infections in the US have been 
reported (Smith, et al., 2011), and all evidence suggests that prevalence of MRSA ST398 is 
sharply below that in many other Western, industrialized countries. This may be because the US 
has a high prevalence of CA- and HA non-ST398 MRSA, and these strains are outcompeting 
MRSA ST398 in the community European countries like Denmark suffered greatly from the 
emergence of ST398 because pre-existing MRSA rates were extremely low, due to effective 
“search and destroy” policies.  However, these policies did not target pig farming as a risk factor 
for MRSA colonization prior to 2006, leaving healthcare systems vulnerable once ST398 
emerged. Now, ST398 comprises 30% of Denmark’s MRSA cases, and the country is experiencing 
the highest rates of MRSA since 1985 (Statens Serum Institut et al., 2010).  
Prevalence of MSSA ST398 in the general US population appears to be much higher than 
MRSA ST398, and MSSA ST398 may even be common in some regions. A recent study found that 
MSSA ST398 was one of the most common noninvasive MSSAs recovered from clinical patients 
in Northern Manhattan, and invasive MSSA ST398 was recovered, as well (Uhlemann, et al., 
2012). The same study found approximately 20% of households in Northern Manhattan to be 
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contaminated with MSSA ST398, either as a human colonizer or on environmental surfaces. 
More than one human was colonized with MSSA ST398 in 20% of multi-person households 
contaminated with this strain; there were fewer concordant dyads for all other S. aureus strains 
examined (Uhlemann, et al., 2012).  Another study from the Northeastern US recently described 
several infections in the Manhattan area due to MSSA ST398 and MSSA ST291, a novel sequence 
type belonging to CC398 (Mediavilla, et al., 2012). Most isolates were not multidrug-resistant, 
and all were acquired from individuals with no history of livestock exposure. Both of these 
studies suggest at least low-level prevalence of human-associated MSSA ST398 in the New York 
City area, and efficient transmission among households independent of livestock contact.  
Unanswered Questions 
Livestock-associated MRSA has been actively observed in the human population for less 
than ten years, and many questions remain regarding its origins, evolution, and changing 
epidemiology. Of common interest are questions regarding the timing of LA-MRSA emergence in 
humans. MRSA ST398 has not been detected in any human isolate archived prior to 2004, yet 
evidence suggests that SCCmec IV and V have been introduced into MSSA ST398  multiple times 
(Graveland, et al., 2011). It is unclear why LA-MRSA never emerged in the years, or even 
decades, prior to 2004. No changes to husbandry practices were made prior to 2004, nor were 
any clear changes made in antibiotic use (though it is speculated that Europe’s introduction of 
3rd generation cephalosporins for use in piglets in the 90s may be related to the emergence of 
LA-MRSA). Also unclear is why LA-MRSA occurs as ST9 in China and Malaysia (Smith, et al., 
2011). Many LA-MRSA ST9 isolates are spa type t899; this same spa type is found in ST398 as 
well, suggesting the two strains are related (Smith, et al., 2011).  Most important are 
uncertainties regarding the future of ST398 in the community. It is unknown whether or not 
these strains could become better adapted to human hosts, and therefore pose an even greater 
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risk to global public health. Some evidence shows that accretion of human-specific MGEs, 
including virulence genes, is already occurring (Skov, 2011). If transmission of ST398 among 
humans begins to rise, resistance to human-specific antibiotics may also become more 
prevalent. Serious infections by ST398, including endocarditis, bloodstream infections, and 
necrotizing pneumonia, may become more common if the fitness, virulence, and/or resistance 
of ST398 increase. 
Multidrug-resistant S. aureus 
Multidrug-resistant S. aureus (MDRSA) is typically defined as S. aureus that 
demonstrates resistance to three of more classes of drugs. MDRSA can include MRSA, but 
multiply-resistant S. aureus that do not exhibit methicillin-resistance are common. Infections 
with such bacteria can present treatment challenges comparable to MRSA, and multidrug-
resistant, pvl-positive MSSA strains are thought to be contributing to the ongoing epidemic of 
CA-MRSA infections in the US (Orscheln et al., 2009). However, prevalence and characteristics of 
general MDRSA carriage in the US population are unknown. Risks for MDRSA acquisition are also 
unknown, but are likely similar to risks for MRSA acquisition (See: Epidemiology of S. aureus 
carriage). 
MDRSA Associated with CAFOs 
Prior to the emergence of ST398 in the US, the link between industrial livestock 
production and an environmental reservoir of MDRSA had already been established.  A 2006 
study found airborne MDRSA downwind from two swine CAFOs in the Midwestern US. S. aureus 
was the most prevalent bacteria sampled from the interiors of these two CAFOs, comprising 
over 75% of all recovered bacteria. Concentrations of S. aureus decreased with increasing 
distance downwind, although airborne S. aureus was still detectable 150 m downwind of both 
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facilities. Resistance to 4 antibiotic classes was evaluated; a significant difference was detected 
in S. aureus resistance to oxytetracycline (p=.010), tetracycline (p=.014), ampicillin (p=.007), and 
erythromycin (p=.035) when samples taken upwind and samples taken immediately downwind 
of the facilities were compared (Gibbs et al., 2006). Several other studies have found S. aureus 
to be the most prevalent microorganism captured by filtration and impaction of bioaerosols 
inside CAFO barns, although none of these studies have measured antibiotic resistance in S. 
aureus isolates (Butera et al., 1991; Crook et al., 1991; Predicala et al., 2002). 
 MDRSA has also been isolated from flies collected near poultry CAFOs in Maryland 
(Graham, et al., 2009). Antibiotic-resistant bacteria can be ingested by flies as they feed on 
decomposing waste and animal carcasses, or they can stick to their legs, feet, wings, or 
proboscis. Bacteria can then be transferred to new surfaces through regurgitation or physical 
contact.  A 2009 study found that 10-15% of S. aureus isolates collected from flies trapped 100-
200 m from poultry CAFOs were MDR (n=27), while approximately 30% of S. aureus isolates 
collected from nearby poultry litter piles were MDR (n=118) (Graham, et al., 2009). While the 
species of flies collected in this study have a typical traveling radius of 2 miles, individual flies 
can fly up to 20 miles. Flies carrying MDRSA present an additional route for human exposure.  
Research rationale 
Staphylococcus aureus is a ubiquitous human and animal commensal carried by 
approximately one third of the U.S. population, primarily in the nares (Gorwitz, et al., 2008). S. 
aureus is also an adept human pathogen capable of causing a wide range of infections, from 
surficial to systemic (Loir, et al., 2003; Lowy, 1998).  In recent years, rapidly disseminating 
multidrug-resistant strains of S. aureus (MDRSA) have made treatment of S. aureus infections 
more protracted, more burdensome, and less successful (Chambers, et al., 2009). In particular, 
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strains of S. aureus resistant to methicillin (MRSA) have proven increasingly difficult to treat 
(Chambers, et al., 2009).  
 Industrial livestock operations may be a source of exposure to antibiotic-resistant S. 
aureus, including MDRSA and MRSA.  In addition to confining hundreds of animals in enclosed 
spaces, industrial livestock operations administer 80% percent of all antibiotics sold in the US to 
food animals for the purposes of treatment, prophylaxis, and growth promotion (Food and Drug 
Administration, 2009). These practices have been associated with a growing animal and 
environmental reservoir of novel antibiotic-resistant pathogens, including antibiotic-resistant S. 
aureus (Frank M. Aarestrup, 1995; Gibbs, et al., 2006; Graham, et al., 2009). Some clones of 
antibiotic-resistant S. aureus can be zoonotically transmitted to individuals in close contact with 
livestock (Catry et al., 2010), who may then be at an increased risk for infection (Wertheim, et 
al., 2005). Of particular concern is the recent emergence of a new livestock-associated S. aureus 
clone, clonal complex 398 (CC398), which is responsible for an increasing percentage of MRSA 
infections in several countries, including Denmark, Germany, and the Netherlands (Smith, et al., 
2011; Statens Serum Institut, et al., 2010).  
Despite growing attention in Europe, much is unknown about the carriage of antibiotic-
resistant S. aureus by livestock workers and their household members in the US. Only one 
published study has examined MRSA carriage in industrial livestock workers (Smith, et al., 2009), 
and no study has comprehensively examined the antibiotic resistance profiles of S. aureus 
colonizing workers and their household members to determine multidrug-resistance. 
Furthermore, carriage of antibiotic-resistant S. aureus by individuals exposed to antibiotic-free 
livestock operations has not yet been studied in the US. It is therefore unknown whether or not 
workers and household members exposed to industrial livestock operations are at a greater risk 
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of carrying antibiotic-resistant S. aureus, including MDRSA and MRSA, than workers and 
household members exposed to antibiotic-free livestock operations.  
 North Carolina presents an ideal setting for an investigation of the prevalence of S. 
aureus, MDRSA, and MRSA among livestock workers in the United States.  North Carolina is the 
second largest producer of hogs in the country and the third largest producer of poultry. The 
vast majority of these animals are housed from birth to slaughter in industry-owned 
concentrated animal feeding operations (CAFOs). North Carolina, however, is also home to a 
burgeoning sustainable farming movement (Greene, 2010).  These farms raise pork and poultry 
without the use of antibiotics and with limited reliance on external inputs. Therefore, we 
conducted a study (1) to compare the prevalence of carriage of MDRSA and MRSA in industrial 
livestock workers and household members to antibiotic-free livestock workers and household 
members in North Carolina, (2) to compare antibiotic resistance patterns among S. aureus-
positive individuals in both groups, and (3) to determine whether or not CC398 is present in 
North Carolina livestock workers and their household members. Furthermore, based on a lack of 
consensus in the literature regarding which commercial media is ideal for isolating S. aureus, this 
research aims to compare the sensitivity and specificity of two differential media, Baird Parker 
and BBL™ CHROMagar™ Staph aureus, in their capacity to detect S. aureus from nasal swabs.
  
 
CHAPTER 2: METHODS 
Study design and timeframe 
All participants were recruited for this study by snowball sampling, beginning in early 
2011.  Industrial workers and household members were recruited with the help of two 
community organizations based in eastern North Carolina, the Rural Empowerment Association 
for Community Help (REACH) and the North Carolina Environmental Justice Network (NCEJN). 
ABF farmers and household members were mainly recruited by a team of researchers at the 
UNC Gillings School of Global Public Health, though a small number of ABF famers and 
household members were also recruited by REACH. Enrollment for this study began in May, 
2011 and ended in December, 2011.  
All workers employed in North Carolina were eligible to participate in this study, 
providing they reported contact with swine or poultry, were eighteen years or older, and spoke 
either English or Spanish. Up to two household members, including minors (ages 7-17), were 
also invited to participate if they reported living in the same household as a livestock worker for 
the past three months.  
This study and all of its protocols were approved by UNC Chapel Hill’s Institutional 
Review Board. Recruitment materials and questionnaires were also available in Spanish.  
Administration of Questionnaires and Nasal Swab Sample Collection 
Once a participant was enrolled, a follow-up visit was planned at a location of the 
participant’s choosing (usually the home, in the case of IND and PP participants, or the farm, in 
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the case of ABF participants) to obtain questionnaire data and a nasal swab. The questionnaire 
assessed risk factors for MRSA colonization, including occupational exposures, household and 
environmental exposures, personal activities, and medical history, as well as basic 
demographics, including race, sex, and education level. Each member of a household completed 
a separate questionnaire.   
 Next, a swab of each participant’s nostrils was taken by the interviewer. A single, sterile 
BD BBLTM CultureSwabTM was used to swab both nostrils. Most interviewers were trained in 
proper swabbing protocol by a member of the nursing staff at UNC hospitals prior to the start of 
the study; all other interviewers were trained by an individual who had attended that training 
session. Swabs were immediately inserted into Stuart’s transport medium and stored at 4°C 
until arrival at the UNC School of Public Health. Swabs were transported by courier on ice in an 
insulated storage container within five days of collection.   
Isolation of MSSA and MRSA from Nasal Swabs 
Upon arrival in the laboratory, swabs were inoculated into 10 ml of Mueller-Hinton 
broth (MHB) with 6.5% NaCl, then incubated overnight at 37°C (Figure 3).  To isolate 
presumptive MSSA, a loopful of enriched broth was streaked onto Baird-Parker with Egg Yolk 
Tellurite Enrichment (BP) and CHROMagar™ Staph aureus (CS) plates (Beckton, Dickinson and 
Company, Franklin Lakes, NJ). Plates were incubated at 37°C for 24 hours. Colonies with 2 out of 
3 morphological characteristics for S. aureus growth on BP (black, shiny, with clearing) and CS 
(mauve, matte, with halo) were streaked to isolation on the same media on which they were 
isolated, then archived in Brain Heart Infusion broth (BHIB) with 15% (by volume) glycerol added 
for cryopreservation at -80°C. To isolate presumptive MRSA, 1 ml of MHB was transferred to 10 
ml of Tryptic Soy broth (TSB) with 2.5% NaCl, 3.5 mg/L cefoxitin, and 10 mg/L aztreonam, and 
incubated overnight at 37°C. Isolation of presumptive MRSA colonies then followed using  
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Tryptic soy broth with 2.5% 
NaCl, 3.5 mg/L cefoxitin, and 
10 mg/L aztreonam 
Mueller-Hinton 
broth with 6.5% 
NaCl 
 
BBL™ CultureSwab™ stored in Liquid Stuart 
 medium at 4°C until arrival at lab 
  
  
            
          Arm 1: MSSA isolation  
 
       Arm 2: MRSA Isolation 
Incubate each selective enrichment overnight at 37°C 
 
 
   
Baird-Parker CHROMagarTM Staph 
aureus  
Baird-Parker CHROMagar
TM
 Staph 
aureus 
 
Incubate 24 h at 37°C 
 
Isolate up to two colonies from each plate with S. aureus morphology, 
then streak to isolation 
 
Inoculate cultures into 15% glycerol Brain Heart Infusion broth,  
then archive at -80°C 
 
Presumptive S. aureus undergo: 
DNA Extraction using 
Qiagen DNEasy Blood & 
Tissue kit; 
Multiplex PCR for 16S, nuc, 
and mecA genes; 
Antibiotic susceptibility-
testing via disk-diffusion 
   
Final confirmation of S. aureus by catalase and coagulase testing 
 
Figure 3. Protocol for isolation and characterization of MSSA and MRSA from nasal swabs.  
Adapted from: (Davis et al., 2012) 
Transfer 1 ml 
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exactly the same procedure as isolation of presumptive MSSA. A more detailed schematic of this 
process is provided in Figure 3. Approximately 10 swabs were processed each week using this 
method between May and December, 2011. This protocol was largely adapted from Davis et al. 
(2012). 
Molecular Confirmation of MSSA and MRSA 
At least two isolates from each individual with presumptive S. aureus (one from each 
type of media, if available) were regrown from frozen stocks and extracted using Qiagen’s 
DNeasy Blood & Tissue kit, with a modified protocol for gram-positive bacteria recommended by 
the manufacturer. Primers from a multiplex PCR were used to amplify the 16S, nuc, and mecA 
genes in all extracted isolates (Poulsen et al., 2003). Primer sequences are provided in Table 3. 
PCR conditions were as follows: (25 µl total volume): 2.5 µl 10x buffer (Qiagen, Valencia, CA), 5 
nmol each dNTP, 5 pmol each of the 6 primers, 1 unit HotStarTaq DNA polymerase (Qiagen, 
Valencia, CA), and 1 µl of template. Amplification was carried out on a Bio-Rad Gene CyclerTM 
thermal cycler with the following program: 15 min at 95°C; then 30 cycles of 30 s at 94°C, 30 s at 
55°C and 60 s at 72°C; followed by elongation for 10 min at 72°C. A clinical strain of Mu50 MRSA 
was used as a positive control (courtesy of Dr. Melissa Miller, UNC School of Medicine). 
Amplified gene products were separated by electrophoresis on 1.5% agarose gels and visualized 
by ethidium bromide staining. Isolates that were positive for the 16S and nuc genes but negative 
for the mecA gene were considered MSSA; isolates that were positive for all three genes were 
considered MRSA. Catalase and tube coagulase testing with rabbit plasma (BD BBTM, Franklin 
Lakes, NJ) were subsequently performed on at least one PCR-confirmed S. aureus isolate (MSSA 
or MRSA) per person to validate molecular findings.  
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Table 3. Primer sequences used for multiplex PCR 
Gene target Direction Sequence (5’ -- 3’) Product Size (bp) 
16S F GTG CCA GCA GCC GCG GTA A 886 
R AGA CCC GGG AAC GTA TTC AC 
nuc F TCA GCA AAT GCA TCA CAA ACA G 527 
R CGT AAA TGC ACT TGC TTC AGG 
mecA F GGG ATC ATA GCG TCA TTA TTC 255 
R AAC GAT TGT GAC ACG ATA GCC 
Source: (Poulsen, et al., 2003) 
Antibiotic Susceptibility Testing 
At least one isolate per S. aureus-positive individual (92 total) was assessed for its 
susceptibility to 12 classes of antibiotics using the Kirby-Bauer disk diffusion method (Table 4). 
Standard procedures were used and diameter interpretations were based on Clinical and 
Laboratory Standards Institute guidelines (Clinical and Laboratory Standards Institute, 2010).  
Inducible clindamycin resistance in erythromycin-resistant isolates was evaluated using the D-
zone test (Steward et al., 2005). Additionally, vancomycin resistance was assessed in at least one 
isolate per S. aureus-positive individual (92 total) on Brain Heart Infusion agar supplemented 
with 5 mg/L vancomycin hydrochloride (Brown et al., 2005). 
Isolates that demonstrated full resistance to three or more classes of antibiotics were 
classified as MDRSA. Because variable resistance profiles are possible among S. aureus isolates 
from the same individual, additional isolates from a subset of individuals determined not to 
have MDRSA (n=36) were assessed for their susceptibility to the antibiotics listed in Table 4. 
Complete resistance to oxacillin and intermediate or complete resistance to ceftriaxone were 
interpreted as methicillin resistance. 
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Table 4. Antibiotics used in susceptibility testing via disk diffusion 
Antibiotic Class Concentration  Importance to Human Healtha 
Ampicillin β-lactam 10 µg Critical 
Ceftriaxone Cephalosporin 30 µg Critical 
Ciprofloxacin Floroquinolone 5 µg Critical 
Clindamycin Lincosamide 2 µg Important 
Erythromycin Macrolide 15 µg Critical 
Gatifloxacin Floroquinolone 5 µg Critical 
Gentamicin Aminoglycoside 10 µg Critical 
Levofloxacin Floroquinolone 5 µg Critical 
Linezolid Oxazolidone 30 µg Critical 
Oxacillin β-lactam 1 µg Highly Important 
Penicillin β-lactam 10 units Critical 
Quinupristin/Dalfopristin Streptogramin mix 15 µg Critical 
Rifampin Rifamycin 5 µg Critical 
Sulfamethoxazole/ 
Trimethoprim 
Sulfonamide mix 23.75/1.25 µg Highly Important 
Tetracycline Tetracycline 30 µg Highly Important 
Vancomycin Glycopeptide 5 µg; 5 mg/L Critical 
a. As classified by the World Health Organization (Second World Health Organization Expert Meeting, 
2007).  Antibiotics were classified from lowest to highest priority: Important, Highly Important, and 
Critical. 
Confirmation of CC398 and additional gene targets 
A lineage-specific PCR was used to detect CC398 in one isolate from each S. aureus-
positive individual, using amplification conditions described elsewhere (Marc Stegger et al., 
2011). Two µl of template was used in 2.5x 5 PRIME MasterMix (5 PRIME Inc., Gaithersburg, 
MD), with final primer concentrations of 2 pM. Amplified gene products were separated by 
electrophoresis on 1.5% agarose gels and visualized by ethidium bromide staining. A ST398 
MRSA isolate was used as a positive control (courtesy of Dr. Tara Smith, University of Iowa) and 
purified PCR-grade water was used as a negative control. 
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PCR for the czrC gene was performed on all MRSA CC398 isolates identified by the 
lineage-specific PCR described above. Two µl of template was used in 2.5x 5 PRIME MasterMix 
(5 PRIME Inc., Gaithersburg, MD), with final primer concentrations of 2 pM. Primer sequences 
are described elsewhere (L. M. Cavaco et al., 2010). Amplification was carried out on a Bio-Rad 
Gene CyclerTM thermal cycler with the following program: 4 min at 94°C; then 30 cycles of 1 min 
at 94°C, 1 min at 55°C and 1 min at 72°C; followed by elongation for 10 min at 72°C. Amplified 
gene products were visualized as described above. A ST398 MRSA isolate (courtesy of Dr. Tara 
Smith, University of Iowa) was used a positive control and purified PCR-grade water was used as 
a negative control. 
PCR was also used to detect the pvl gene in one pure isolate from each S. aureus-
positive individual, using amplification conditions described elsewhere (Lina et al., 1999). Two µl 
of template was used in 2.5x 5 PRIME MasterMix (5 PRIME Inc., Gaithersburg, MD), with final 
primer concentrations of 2 pM. Amplified gene products were visualized as described above. S. 
aureus ATCC 25923 was used as a positive control and purified PCR-grade water was used as a 
negative control. 
 
 
 
 
 
CHAPTER 3: RESULTS 
Prevalence of S. aureus, MDRSA, and MRSA 
In total, 105 antibiotic-free (ABF) farmers and household members and 99 industrial 
(IND) workers and household members participated in this study. Additionally, 30 industrial 
processing plant (PP) workers and household members participated; these individuals were 
separated from the IND category post-enrollment due to workers’ lack of contact with live 
animals. A detailed summary of study participants is presented in Table 5.   
Table 5. Summary of study participants 
 Antibiotic-free  
(ABF) 
Industrial 
(IND) 
Processing plant 
(PP) 
Participant    
         Worker 92 80 18 
         Adult household member 4 10 8 
         Minor household member 9 9 4 
         TOTAL 105 99 30 
 
S. aureus was isolated from 41 IND participants (n=99), 42 ABF participants (n=105), and 
9 PP participants (n=30) (Figure 4). Among these, 37% of S. aureus-positive IND participants 
carried MDRSA, as did 19% of S. aureus-positive ABF participants and 33% of S. aureus-positive 
PP participants (data not shown). Additionally, MRSA was detected in 3/41 S. aureus-positive 
IND participants and 3/42 S. aureus-positive ABF participants (Figure 4).  All six of these 
individuals were workers reporting direct contact with swine or poultry. Two out of nine S. 
aureus-positive PP participants also tested positive for MRSA (Figure 4), but both of these 
individuals were household members who did not report contact with swine or poultry, and 
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Figure 4. Carriage of S. aureus, multidrug-resistant S. aureus (MDRSA), and methicillin- 
resistant S. aureus (MRSA) in each study group. 
Note: MDRSA and MRSA are sub-categories of S. aureus and are not independent of one another. 
 
who had additional risk factors for MRSA carriage. MRSA prevalence in all three groups was 
higher than MRSA prevalence in the general US population, 1.5% (Gorwitz, et al., 2008).  
 
 
Not all MRSA detected in this study were multidrug-resistant (Figure 5). Both MRSA-
positive individuals from the PP group carried multidrug-resistant MRSA while 2/3 of MRSA-
positive individuals from the IND group carried multidrug-resistant MRSA. None of the MRSA 
isolates collected from the ABF group were multidrug-resistant. 
MRSA isolated from one PP participant was pvl-positive (data not shown). No other 
tested S. aureus isolate carried the pvl gene.  
  
Figure 5. Antibiotic resistance profiles of 8 MRSA isolates collected during study.  
SXT: sulfamethoxazole/trimethoprim; VAN: vancomycin; LZD: linezolid; GEN: gentamicin; CLI: clindamycin; 
GAT: gatifloxacin; LEV: levofloxacin; CIP: ciprofloxacin; SYN: quinupristin/dalfopristin; ERY: erythromycin; 
TET: tetracycline; CEF: ceftriaxone; OXA: oxacillin; PEN: penicillin; AMP: ampicillin; MDR: multidrug-
resistant 
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It should be noted that the protocol used in this study failed to differentially isolate 
MRSA and MSSA from nasal swabs, as it was intended to do. Much of the “presumptive MRSA” 
isolated in Arm 2 of the study protocol (Figure 3) was in fact MSSA, as confirmed by PCR. It is 
hypothesized that MSSA were not completely eliminated during the overnight incubation in TSB 
with 2.5% NaCl, 3.5 mg/L cefoxitin, and 10 mg/L aztreonam. Once TSB enrichments were plated 
on to antibiotic-free BP and CS plates, any MSSA still remaining were able to flourish.  
Resistance phenotypes  
The antibiotic resistance profiles of S. aureus isolated from each study population were 
also assessed. A broad range of antibiotic resistance was observed in all three groups. Of the 
twelve classes of drugs tested (Table 5), resistance was observed to all except oxazolidones 
(linezolid), glycopeptides (vancomycin), and sulfonamides (sulfamethoxazole/trimethoprim). 
Rifamycin resistance was observed in only one ABF worker, while streptogramin resistance was 
observed in only one PP household member. Aminoglycoside resistance was unique to the IND 
group and was observed in two separate workers and an unrelated household member. 
In total, ABF workers and household members demonstrated resistance to fewer classes 
of drugs than either the IND or PP group (5 classes versus 6 and 7, respectively; Figure 6). 
Furthermore, ABF workers and household members demonstrated the least prevalence of 
resistance to tetracyclines, macrolides, and β-lactams, the three classes of drugs for which all 
three groups demonstrated resistance. 
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Figure 6. Percentage of S. aureus-positive ABF, IND, and PP participants demonstrating full 
resistance to 9 antibiotic classes. 
  
Tetracycline resistance was unique to the IND group (χ²=21.92, df=2, p-value <0.0001) 
with over 40% of all S. aureus-positive IND participants demonstrating resistance to this 
antibiotic, compared with 22% of S. aureus-positive PP participants and 3% of S. aureus-positive 
ABF participants (Figure 6). Of the 19 IND participants who carried tetracycline-resistant S. 
aureus, 79% were workers who had direct contact with swine, while the remaining 21% 
reported direct contact with poultry.   
Aminoglycoside resistance was also unique to the IND group, with resistance occurring 
in 2 IND workers and 1 IND household member, and no other study participant (Figure 6). 67% 
of individuals carrying gentamicin-resistant S. aureus reported direct or indirect contact with 
poultry. 
Prevalence and Distribution of CC398 
PCR was used to determine if any S. aureus isolated in this study belonged to CC398, the 
clonal complex commonly associated with zoonotic transmission. CC398 was detected in both 
workers and household members in this study, providing the first evidence of CC398 in humans 
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Figure 7. Prevalence of CC398 among S. aureus-positive IND, ABF, and PP participants. 
in North Carolina (Figure 7). Seventeen of 41 S. aureus-positive IND participants carried CC398, 
as did 3/42 S. aureus-positive ABF participants. Ninety-four percent of CC398-positive 
participants were workers who reported direct contact with livestock.  No CC398 was identified 
in the PP group.  
 
 
No MRSA CC398 was detected among ABF or PP participants, and only 2 cases of MRSA 
CC398 were identified among IND participants. Neither of these isolates carried the czrC gene. 
However, MSSA CC398 was present in both groups (Figure 8).  
In the IND group, over 1/3 of all CC398 was multidrug-resistant (Figure 8). No multidrug-
resistant CC398 occurred in the ABF group.  
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a)  MSSA vs. MRSA 
 
 
b) MDRSA vs. resistant to ≤2 classes of drugs 
 
 
Figure 8. Distribution of CC398 among S. aureus-positive IND, ABF, and PP participants. 
 
Resistance phenotypes of CC398 isolates 
Nearly 1/3 of CC398 isolates collected in this study exhibited resistance patterns 
inconsistent with patterns characteristic of livestock-associated ST398. 1 ABF worker, 1 ABF 
household member, and 4 IND workers in this study were colonized with tetracycline-
susceptible MSSA CC398, despite reporting direct contact with livestock (Figure 9). All six 
tetracycline-susceptible MSSA CC398 isolates demonstrated resistance to penicillin, and isolates 
from one IND worker demonstrated additional resistance to clindamycin and erythromycin.  
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Figure 9.  Antibiotic resistance profiles of 20 CC398 isolates collected during study. 
CEF: ceftriaxone; OXA: oxacillin; CLI: clindamycin; ERY: erythromycin; TET: tetracycline; PEN: penicillin; 
AMP: ampicillin; MDR: multidrug-resistant 
 
  
 
Sensitivity and specificity comparisons 
Results from two different media used to isolate S. aureus during this study are shown 
in Table 6. The sensitivity and specificity for detecting S. aureus from human nasal swabs using 
Baird-Parker media were 80.7% and 95.5%, respectively.  Results from 216 individuals were 
included in these calculations because BP media was unavailable during one week of sample 
collection. The sensitivity and specificity of CHROMagar™ Staph aureus was 90.1% and 95.4%, 
respectively. Results from 222 individuals were included in these calculations for the same 
reason (unavailability of media). Nasal swabs were incubated overnight in selective enrichment 
broth prior to plating to increase sensitivity on both types of media (Safdar et al., 2003).  
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Table 6. Sensitivity and specificity of (a) Baird-Parker and (b) CHROMagar Staph aureus 
media for isolation of Staphylococcus aureus from nasal swabs 
 
               Baird-Parker                  CHROMagar™ Staph aureus 
 PCR + PCR - Total   PCR + PCR - Total 
Morphology + 67 6 73  Morphology + 82 6 88 
Morphology - 16 127 143  Morphology - 9 125 134 
Total 83 133 216  Total 91 131 222 
  
Identifying colonies as presumptive S. aureus based on expression of only 2 out of 3 
morphological characteristics was critical in ensuring that no S. aureus were missed. Of the 67 
individuals correctly identified as S. aureus-positive using BP, 17.9% would not have been 
identified if only those colonies expressing all three characteristics (black, shiny, with clearing) 
were archived. Of the 82 individuals correctly identified using CS, 26.9% would not have been 
identified if only those colonies expressing all three characteristics (mauve, matte, with halo) 
were archived. 
Only 69.6% of S. aureus-positive participants were identified by both BP and CS; the 
remaining 30.4% were identified by one type of media or the other. While some of this loss can 
be attributed to human error and inherent variability in media quality, these results suggest that 
using at least two types of media to isolate S. aureus from nasal swabs improves recovery. 
However, using two types of media may be cost- and time-prohibitive. Our findings suggest that 
CHROMagar™ Staph aureus may be a more productive media for S. aureus isolation from human 
nasal swabs than Baird-Parker with Egg Yolk Tellurite Enrichment. CHROMagar™ Staph aureus 
demonstrated higher sensitivity and comparable specificity to Baird-Parker media in this study.
 
 
 
 
 
CHAPTER 4: DISCUSSION 
This study provides the first report of CC398 in livestock workers and household 
members in North Carolina. MSSA CC398 was detected in both IND and ABF participants, 
although MRSA CC398 only occurred in industrial workers. We observed only 2 cases of MRSA 
CC398 among 99 sampled industrial participants, a sharply lower incidence than what has been 
observed in previous studies in North America (Khanna, et al., 2008; Smith, et al., 2009). Most 
cases of CC398 occurred in individuals with direct exposure to livestock.  
Interestingly, 30% of CC398 detected in this study was tetracycline-susceptible. 
Tetracycline resistance is commonly considered a hallmark of livestock-associated ST398 (MSSA 
or MRSA) (Frank Møller Aarestrup et al., 2010), though resistance is rare among human-
associated ST398 isolates (Uhlemann, et al., 2012). Human-associated ST398 detected in the US 
thus far has consistently demonstrated resistance to penicillin, and resistance to clindamycin 
and erythromycin is common as well (Mediavilla, et al., 2012; Uhlemann, et al., 2012). These 
findings suggest that CC398 in North Carolina may be different from livestock-associated CC398 
isolated in previous studies. Whole genome sequence typing will be used to elucidate the 
evolutionary relationship of all CC398 identified in this study to a diverse collection of ST398 
isolates described elsewhere (Price, et al., 2012).  
This study provides evidence of a significantly higher prevalence of multidrug-resistant 
S. aureus among individuals exposed to industrial livestock production and processing plants, in 
comparison to individuals exposed to antibiotic-free operations. However, we cannot calculate 
adjusted relative risk estimates for MDRSA carriage based on occupational exposure because 
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the study groups were highly dissimilar – lacking collapsibility. The ABF group was mostly 
Caucasian, middle class, and college-educated, while individuals in the IND and PP group were 
largely Hispanic, of lower socioeconomic status, and less educated (data not shown). 
Additionally, there were wide differences in the distribution of traditional risk factors for MDRSA 
and MRSA colonization. Members of the ABF group were more likely to have used antibiotics 
within the past year, to have a pet inside the home, and to have recently visited a gym or played 
contact sports. However, it is important to that note our findings are in accordance with 
previous European studies which showed a higher prevalence of antibiotic-resistant S. aureus 
among industrial livestock workers compared with antibiotic-free livestock workers (Blaha et al., 
2010; Graveland et al., 2010; Wulf, Nes, et al., 2008).  Furthermore, despite having more risk 
factors for MDRSA and MRSA colonization, ABF participants had a lower prevalence of MDRSA 
than either the IND or PP group, and had a similar prevalence of MRSA.  
Additionally, we observed unique resistance to tetracyclines and gentamicin in 
individuals from the industrial group. 40% of all S. aureus-positive IND participants 
demonstrated resistance to tetracycline, and 79% of these individuals were workers reporting 
direct contact with swine. Tetracyclines are one of the most common antimicrobials 
administered to swine for the purpose of growth promotion. Nearly 50% of the 10 million 
pounds of antimicrobials fed to swine each year belong to this class (Mellon, et al., 2001), and 
reliance on tetracyclines in industrial swine production is estimated to be growing (Mellon, et 
al., 2001). Tetracyclines are also used in poultry production, but less frequently due to high 
resistance among animals (McEwen et al., 2002).  Aminoglycoside resistance was also uniquely 
observed among industrial participants. Aminoglycosides are used for growth promotion in 
poultry, and gentamicin is reported to be the most frequently used antibiotic in poultry 
production (Price et al., 2007). 67% of individuals demonstrating resistance to gentamicin in the 
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industrial group reported direct or indirect contact with poultry. Aminoglycosides such as 
gentamicin, neomycin, and streptomycin are administered to swine for therapeutic and 
prophylactic purposes only.  
Lastly, based on our comparison of S. aureus-selective media, we conclude that using at 
least two types of media to isolate S. aureus from enriched nasal swabs is helpful to ensure that 
all S. aureus-positive individuals would be identified in a sample population. While 
CHROMagar™ Staph aureus demonstrated higher sensitivity than Baird-Parker and comparable 
specificity, 30.4% of S. aureus-positive participants would not have been identified if only one 
type of media had been used in this study. These findings should inform future studies 
evaluating the presence of S. aureus on enriched nasal swabs.  
Limitations and Future Research 
There were several limitations to our study. First, as described previously, demographic 
differences in our study populations precluded an exploration of relative risks of MDRSA, MRSA, 
and CC398 carriage based on occupational exposures, adjusting for potential confounding 
covariates. This means that there is likely uncontrolled residual confounding in our study. Such 
wide racial and socioeconomic disparities were not anticipated at the start of our study, but are 
likely reflective of differences between populations of IND and ABF livestock workers in the 
Southeastern United States.  
Second, we were unable to sample livestock or the production/work-place environment 
for the presence of antibiotic-resistant S. aureus, including CC398. Animal and environmental 
sampling would be critical in future studies to elucidate sources of transmission of antibiotic-
resistant S. aureus to livestock workers and their household members, as well as to provide 
insight into directionality of transmission (i.e., animal to human versus human to animal). 
Sampling of farms would have thus provided stronger evidence for an association between 
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carriage of MDRSA, MRSA, and/or CC398 and occupational exposure. However, industrial animal 
operations in eastern North Carolina were not accessible to our research team. 
 Third, because our study design was not able to fully target processing plant workers or 
household members, a smaller number of individuals were sampled. This means that our results 
cannot be considered characteristic of all PP workers or household members of livestock 
workers in North Carolina. However, important differences in carriage of MDRSA, MRSA, and 
CC398 carriage in the PP group compared to the ABF and IND groups were evident even from 
our small sample size (n=30). High prevalence of multidrug-resistant S. aureus among PP 
participants demonstrates a need for additional research focusing on this population.  
Lastly, because we only took a nasal swab from participants at one point in time, we 
were unable to determine whether carriage of antibiotic-resistant bacteria, including CC398, 
was due to transient contamination of the nasal passages or true colonization over a longer 
period of time. While several studies have found carriage of livestock-associated MRSA ST398 to 
be transient and dependent on animal contact (Graveland, et al., 2011; van Cleef, et al., 2011; 
Van Den Broek, et al., 2009), a more recent study suggests that carriage may persist regardless 
of lack of animal contact (Robin Köck, et al., 2012). Future studies should incorporate 
longitudinal follow-up involving repeated measures of S. aureus carriage in IND workers, to help 
improve understanding of the persistence of antibiotic-resistant S. aureus in these populations. 
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